A Global Phase I Clinical Study Comparing the Safety and Pharmacokinetics of Proposed Biosimilar BAT1706 and Bevacizumab (Avastin (Record no. 29619515)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01604 a2200433 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250518034641.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201911s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1179-190X |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1007/s40259-019-00352-7 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Wu, Xiaoyun |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20191118 |
245 00 - TITLE STATEMENT | |
Title | A Global Phase I Clinical Study Comparing the Safety and Pharmacokinetics of Proposed Biosimilar BAT1706 and Bevacizumab (Avastin |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy |
Date of publication, distribution, etc. | Jun 2019 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 335-342 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase I; Comparative Study; Journal Article; Randomized Controlled Trial |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Area Under Curve |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bevacizumab |
General subdivision | pharmacokinetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Biosimilar Pharmaceuticals |
General subdivision | pharmacokinetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Double-Blind Method |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Healthy Volunteers |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Infusions, Intravenous |
General subdivision | methods |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Plasma |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Therapeutic Equivalency |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Young Adult |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wynne, Chris |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Xu, Chenchao |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gan, Yiting |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wang, Chaohe |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Thomas, Bert E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Yu, Jin-Chen |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Li, Shengfeng |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zhang, Li |
773 0# - HOST ITEM ENTRY | |
Title | BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy |
Related parts | vol. 33 |
-- | no. 3 |
-- | p. 335-342 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1007/s40259-019-00352-7">https://doi.org/10.1007/s40259-019-00352-7</a> |
Public note | Available from publisher's website |
No items available.